Acta Neuropathologica Communications

Article	Citations
Clinicopathologic features of two unrelated autopsied patients with Charcot-Marie-Tooth disease carrying MFN2 gene mutation	356
Novel histotypes of sporadic Creutzfeldt–Jakob disease linked to 129MV genotype	183
Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation	113
Pleomorphic xanthoastrocytoma in the multiverse of epigenomics: is it time to recognize the variants?	111
Detection of structural DNA variants in medulloblastomas using optical genome mapping	81
Axonal autophagic vesicle transport in the rat optic nerve in vivo under normal conditions and during acute axonal degeneration	76
Fast and slow strains of misfolded mutant superoxide dismutase 1 in familial amyotrophic lateral sclerosis	72
Correction to: Integrated genomic analysis reveals actionable targets in pediatric spinal cord low-grade gliomas	70
Correction: Investigating genotype-phenotype correlation of limb-girdle muscular dystrophy R8: association of clinical severity, protein biological function and protein oligomerization	66
Amyloid quantification in the oldest-old: selecting regions for optimizing correspondence between postmortem pathology and amyloid PET	60
Histomorphological variations in progressive multifocal leukoencephalopathy correlated with JCV replication in brain lesions: insights from 91 patients	59
High-grade astrocytoma with piloid features: a single-institution case series and literature review	58
MGMT methylation pattern of long-term and short-term survivors of glioblastoma reveals CpGs of the enhancer region to be of high prognostic value	58
Early biomarkers in the presymptomatic phase of cognitive impairment: changes in the endocannabinoidome and serotonergic pathways in Alzheimer's-prone mice after mTBI	58
Exogenous interleukin 33 enhances the brain’s lymphatic drainage and toxic protein clearance in acute traumatic brain injury mice	56
Tau seeding in cases of multiple sclerosis	55
Regulating microglial miR-155 transcriptional phenotype alleviates Alzheimer’s-induced retinal vasculopathy by limiting Clec7a/Galectin-3+ neurodegenerative microglia	55
Bruton’s tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination	54
Single cell protein profiling of focal cortical dysplasia in a patient requiring multiple resections	51
CUX1::MET fusion defines an indolent subtype of diffuse low-grade glioma, MAPK pathway–altered	51
Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease	51
DNA methylation as a contributor to dysregulation of STX6 and other frontotemporal Lobar degeneration genetic risk-associated loci	51
Neutrophil infiltration and microglial shifts in sepsis induced preterm brain injury: pathological insights	50
Machine learning quantification of Amyloid-β deposits in the temporal lobe of 131 brain bank cases	48
Molecular pathology, developmental changes and synaptic dysfunction in (pre-) symptomatic human C9ORF72-ALS/FTD cerebral organoids	48

Alpha-synuclein seeding activity in postmortem tissues from patients with diffuse and isolated Lewy bodies	47
Prognostic relevance of MIB-1 labeling index in VHL-associated and sporadic spinal hemangioblastomas: a subgroup analysis from a multicentric study	47
Unsupervised machine learning identifies distinct ALS molecular subtypes in post-mortem motor cortex and blood expression data	46
The genomic alterations in glioblastoma influence the levels of CSF metabolites	46
Early axonal injury in fentanyl intoxication	45
Single-cell spatial proteomic imaging for human neuropathology	44
High-plex spatial protein profiling of skeletal muscle biopsies in inflammatory myopathies using the MACSima™ imaging platform: A pilot study	44
NRF2/ARE mediated antioxidant response to glaucoma: role of glia and retinal ganglion cells	44
Dose-dependent CHCHD10 dysregulation dictates motor neuron disease severity and alters creatine metabolism	43
A toxic gain-of-function mechanism in C9orf72 ALS impairs the autophagy-lysosome pathway in neurons	43
Low-intensity open-field blast exposure effects on neurovascular unit ultrastructure in mice	40
Spatiotemporal perturbations of the plasminogen activation system in a rat model of acute organophosphate intoxication	40
4R-tau isoform induction via TDP-43 in neurons in response to insulin: converging signaling pathways with implications for neurodegenerative disease	39
SARS-Cov-2 infection and neuropathological findings: a report of 18 cases and review of the literature	39
Siponimod inhibits disease-associated microglia-T cell interactions in chronic experimental autoimmune encephalomyelitis	39
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve	39
Clinical and functional characterization of a long survivor congenital titinopathy patient with a novel metatranscript-only titin variant	38
ER stress induced immunopathology involving complement in CADASIL: implications for therapeutics	38
Cerebellar granule neurons induce Cyclin D1 before the onset of motor symptoms in Huntington’s disease mice	37
Diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters (DGONC), new name and new problems: an illustration of one case with atypical morphology and biology	37
A microdeletion event at 19q13.43 in IDH-mutant astrocytomas is strongly correlated with MYC overexpression	37
Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumors	37
TrkA activation sustains chemotherapy resistance in chemotolerant medulloblastoma cells	37
Advancing prion diagnostics: full-length human E200K RT-QuIC substrate facilitates prion detection in tear fluid and improves sensitivity in cerebrospinal fluid	37
Torpor induces reversible tau hyperphosphorylation and accumulation in mice expressing human tau	37
Age-dependent interactions of APOE isoform 4 and Alzheimer’s disease neuropathology: findings from the NACC	36
A sellar presentation of a WNT-activated embryonal tumor: further evidence of an ectopic medulloblastoma	35
WFS1 gene delivery rescues visual function in a mouse model of Wolfram syndrome	35
Clinical and inflammatory factors associated with the extent of resection in primary, sporadic vestibular schwannomas: A retrospective study	34
Single-cell transcriptome sequencing reveals new epithelial-stromal associated mesenchymal-like subsets in recurrent gliomas	34
EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma	34
Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders	33
CX3CL1/CX3CR1 axis dysregulation contributes to epileptogenic mechanisms in focal cortical dysplasia	33
Facilitated α-synuclein oligomer sharing among glial cells by a centrally acting connexin inhibitor attenuates a rapidly progressive multiple system atrophy-cerebellar type model by reducing the neuro	32
ROS-regulated SUR1-TRPM4 drives persistent activation of NLRP3 inflammasome in microglia after whole-brain radiation	32
Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion	32
Therapeutic potential of NGF-enriched extracellular vesicles in modulating neuroinflammation and enhancing peripheral nerve remyelination	31
Differential vulnerability of the dentate gyrus to tauopathies in dementias	31
The tumour immune microenvironment is enriched but suppressed in vestibular schwannoma compared to meningioma: therapeutic implications for NF2-related schwannomatosis	31
Correction: Neuroinflammation is associated with Alzheimer’s disease co-pathology in dementia with Lewy bodies	31
VAPB confers selective neuroprotection by driving autophagic degradation of pathogenic aggregates in ALS	31
Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer’s disease	30
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s	30
Accurate detection of pathologic α-synuclein in CSF, skin, olfactory mucosa, and urine with a uniform seeding amplification assay	30
The role of neuromuscular ultrasound in diagnostics of peripheral neuropathies induced by cytostatic agents or immunotherapies	29
Establishment of a patient-derived 3D in vitro meningioma model in xeno-free hydrogel for clinical applications	28
Identification and validation of a tear fluid-derived protein biomarker signature in patients with amyotrophic lateral sclerosis	28
Diagnostic accuracy of a minimal immunohistochemical panel in at/rt molecular subtyping, correlated to dna-methylation profiling	28
A novel ELOVL4 variant, L168S, causes early childhood-onset Spinocerebellar ataxia-34 and retinal dysfunction: a case report	28
Hydrogen peroxide induced by nerve injury promotes axon regeneration via connective tissue growth factor	28

Correction to: Interplay between androgen and CXCR4 chemokine signaling in myelin repair	28
Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma	27
Blood biomarker fingerprints in a cohort of patients with CHRNE-related congenital myasthenic syndrome	27
DNA methylation profiling from cerebrospinal fluid as a diagnostic tool for pineoblastoma	27
Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration	27
Bradykinesia and postural instability in a model of prodromal synucleinopathy with α-synuclein aggregation initiated in the gigantocellular nuclei	26
Viral-mediated knockdown of Atxn2 attenuates TDP-43 pathology and muscle dysfunction in the PFN1C71G ALS mouse model	26
Oedematic-atrophic astrocytes in hepatic encephalopathy	26
Immune stimulation recruits a subset of pro-regenerative macrophages to the retina that promotes axonal regrowth of injured neurons	26
Enhancing mitosis quantification and detection in meningiomas with computational digital pathology	25
Concurrent ependymal and ganglionic differentiation in a subset of supratentorial neuroepithelial tumors with EWSR1-PLAGL1 rearrangement	25
MANF protein expression is upregulated in immune cells in the ischemic human brain and systemic recombinant MANF delivery in rat ischemic stroke model demonstrates anti-inflammatory effects	25
The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson’s disease	25
Decreased PP2A expression and activity represent a therapeutic target for plexiform neurofibroma	25
Decoding key cell sub-populations and molecular alterations in glioblastoma at recurrence by single-cell analysis	25
Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration	25
Myelin in Alzheimer’s disease: culprit or bystander?	25
Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis	25
Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations	25
Regional vulnerability of brain white matter in vanishing white matter	25
Meningeal-tumor interactions define distinct modes of leptomeningeal colonization in Group 3 medulloblastoma	24
A case of primary optic pathway demyelination caused by oncocytic oligodendrogliopathy of unknown origin	24
Dissecting acute neuronal responses to glioblastoma using a dual-interface human iPSC neuronal culture platform	24
Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration	24
Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer’s disease	24
Systemic IGF-1 administration prevents traumatic brain injury induced gut permeability, dysmorphia, dysbiosis, and the increased number of immature dentate granule cells	24
Towards a single-assay approach: a combined DNA/RNA sequencing panel eliminates diagnostic redundancy and detects clinically-relevant fusions in neuropathology	24
Proximity proteomics reveals unique and shared pathological features between multiple system atrophy and Parkinson’s disease	23
Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis	23
Correction: Small molecule treatment alleviates photoreceptor cilia defects in LCA5-deficient human retinal organoids	23
Mass cytometric analysis of the immune cell landscape after traumatic brain injury elucidates the role of complement and complement receptors in neurologic outcomes	22
Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation	22
APOE-ε4 and BIN1 increase risk of Alzheimer’s disease pathology but not specifically of Lewy body pathology	22
MGMT promoter methylation modulates the effect of residual tumor on survival after re-resection of recurrent glioblastoma	22
Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models	22
Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction	22
LXR agonist rescues synaptic dysfunction and degeneration in SPG3A patient-specific iPSC-derived neurons	21
Gene-expression profiling of individuals resilient to Alzheimer's disease reveals higher expression of genes related to metallothionein and mitochondrial processes and no changes in the unfolded prote	21
Toward a generalizable machine learning workflow for neurodegenerative disease staging with focus on neurofibrillary tangles	21
Structural and functional studies of the VAPB-PTPIP51 ER-mitochondria tethering proteins in neurodegenerative diseases	21
The ATXN2 9 bp duplication in SCA3: clarifying evidence and correcting misinterpretations	21
Development, validation, and utility of a clinically applicable methylation classifier for recurrence risk prediction in meningiomas	21
Unveiling the intricate dynamics of the interplay between triple-negative breast cancer cells and the blood-brain barrier endothelium	21
Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease-Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B	21
Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils	21
ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice	21
Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment	20
Epitranscriptomic analysis reveals clinical and molecular signatures in glioblastoma	20
TDP-43 pathology is associated with divergent protein profiles in ALS brain and spinal cord	20
Phenotypically concordant distribution of pick bodies in aphasic versus behavioral dementias	20
Host genetics and gut microbiota influence lipid metabolism and inflammation: potential implications for ALS pathophysiology in SOD1G93A mice	20
Bridging the gap: investigating the role of phosphorylation at the serine 129 site of α-synuclein in VAPB-PTPIP51 interactions	20
Evaluation of Rho kinase inhibitor effects on neuroprotection and neuroinflammation in an ex-vivo retinal explant model	20
PIT-1/SF-1-positive pituitary tumors in patients with acromegaly: transcriptomic perspective	20
Retraction Note: Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy	20
Activated alpha 9 integrin expression enables sensory pathway reconstruction after spinal cord injury	19
NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitors	19
Correction: High-resolution transcriptomics informs glial pathology in human temporal lobe epilepsy	19
Antagonizing Il10 and Il4 signaling via intracerebral decoy receptor expression attenuates Aβ accumulation	19
Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors	19
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma	19
Inflammation alters myeloid cell and oligodendroglial iron-handling in multiple sclerosis	19
H3F3B p.K27I-mutant diffuse midline glioma is a distinct subtype of H3K27-altered diffuse midline glioma	19
Small molecule treatment alleviates photoreceptor cilia defects in LCA5-deficient human retinal organoids	19
Tumor-like proliferation of CCM3 knockout endothelial cells: insights from semaxinib treatment and transcriptome profiling of co-cultures	19
Integrated molecular and detailed anatomical profiling identifies a prognostically adverse subtype of posterior fossa meningiomas: high-risk copy number alterations are associated with midline predile	19
Stimulating VAPB-PTPIP51 ER-mitochondria tethering corrects FTD/ALS mutant TDP43 linked Ca2+ and synaptic defects	19
Blocking peptidyl arginine deiminase 4 confers neuroprotective effect in the post-ischemic brain through both NETosis-dependent and -independent mechanisms	19
Intracranial mesenchymal tumor with (novel) COX14::PTEN rearrangement	19
LCN2/SLC22A17 mediates the phagocytosis of GABAergic synapses by oligodendrocyte progenitor cells and contributes to cancer-induced pain and comorbid anxiety-like behaviors in mice	18
Upregulation of carbonic anhydrase 1 beneficial for depressive disorder	18
Current states in understanding oligodendroglia-mediated neurological issues in neurofibromatosis type 1 (NF1)	18
TDP43 pathology in chronic traumatic encephalopathy retinas	18
MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy	18
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis	18
Copper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse model	18
Distinct forebrain regions define a dichotomous astrocytic profile in multiple system atrophy	18
Repeat length of C9orf72-associated glycine–alanine polypeptides affects their toxicity	18
miRNA-211 maintains metabolic homeostasis in medulloblastoma through its target gene long-chain acyl-CoA synthetase 4	18
Spatio-temporal dynamics of microglia phenotype in human and murine cSVD: impact of acute and chronic hypertensive states	18

Correction: Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain	17
Imaging features and consideration of progression pattern of diffuse hemispheric gliomas, H3 G34-mutant	17
Targeting NAD + biosynthesis suppresses TGF-β1/Smads/RAB26 axis and potentiates cisplatin cytotoxicity in non-small cell lung cancer brain metastasis	17
Progesterone receptor distribution in the human hypothalamus and its association with suicide	17
Pediatric high-grade gliomas with concomitant RB1 and SETD2 alterations and Li-Fraumeni syndrome	17
Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer’s disease	17
Investigating genotype-phenotype correlation of limb-girdle muscular dystrophy R8: association of clinical severity, protein biological function and protein oligomerization	17
Cortical microvascular raspberries and ageing: an independent but not exclusive relationship	16
Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease	16
Usefulness OF SOX10 immunohistochemistry for subtyping diffuse midline gliomas EGFR-altered	16
Single-nucleus multi-omics of Parkinson’s disease reveals a glutamatergic neuronal subtype susceptible to gene dysregulation via alteration of transcriptional networks	16
ApoER2-Dab1 disruption as the origin of pTau-associated neurodegeneration in sporadic Alzheimer’s disease	16
Inhibition of acid sphingomyelinase reduces reactive astrocyte secretion of mitotoxic extracellular vesicles and improves Alzheimer’s disease pathology in the 5xFAD mouse	16
A patient-derived cell model for malignant transformation in IDH-mutant glioma	16
Disseminated diffuse midline gliomas, H3K27-altered mimicking diffuse leptomeningeal glioneuronal tumors: a diagnostical challenge!	16
Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease	16
DNA methylation, combined with RNA sequencing, provide novel insight into molecular classification of chordomas and their microenvironment	16
BCKDK loss impairs mitochondrial Complex I activity and drives alpha-synuclein aggregation in models of Parkinson’s disease	16
Expanding clinicopathologic knowledge in high-grade glioma with pleomorphic and pseudopapillary features (HPAP): a report of two cases	16
Current molecular understanding of central nervous system schwannomas	16
Brain and circulating EV proteome signatures in schizophrenia as prognostic markers for age-related dementia	16
Tau seeding activity in various regions of down syndrome brain assessed by two novel assays	16
Synergistic antitumor effect of temozolomide and perampanel in pediatric glioma: a case report and in vitro validation using patient-derived glioma sphere cells	16
Operationalizing postmortem pathology-MRI association studies in Alzheimer’s disease and related disorders with MRI-guided histology sampling	16
Curative timed NK cell-based immunochemotherapy aborts brain tumour recurrence driven by mesenchymal glioma stem cells	16
Disordered DNA methylation leads to targetable transcriptional plasticity in ATRT	15
Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain	15
The mGluR5 agonist CHPG enhances human oligodendrocyte differentiation	15
Rab7a is required to degrade select blood-brain barrier junctional proteins after ischemic stroke	15
DNA hypomethylator phenotype reprograms glutamatergic network in receptor tyrosine kinase gene-mutated glioblastoma	15
Transcription factor-based classification of pituitary adenomas / PitNETs: a comparative analysis and clinical implications across WHO 2004, 2017 and 2022 in 921 cases	15
Timing of microglial ablation determines protection from tau-mediated neurodegeneration and cognitive decline	15
Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition	15
Muscle transcriptome profiling reveals novel molecular pathways and biomarkers in laminin-α2 deficient patients	15
TDP-43 pathology is sufficient to drive axon initial segment plasticity and hyperexcitability of spinal motoneurones in vivo in the TDP43-ΔNLS model of Amyotrophic Lateral Sclerosis	15
Cryo-EM studies of amyloid-β fibrils from human and murine brains carrying the Uppsala APP mutation (Δ690–695)	15
The neuropathological landscape of small vessel disease and Lewy pathology in a cohort of Hispanic and non-Hispanic White decedents with Alzheimer disease	15
Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue	15
Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer’s disease	15
Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis	15
Trem2-deficiency aggravates and accelerates age-related myelin degeneration	15
TDP-43 overexpression in the hypothalamus drives neuropathology, dysregulates metabolism and impairs behavior in mice	15
Severe ACTA1-related nemaline myopathy: intranuclear rods, cytoplasmic bodies, and enlarged perinuclear space as characteristic pathological features on muscle biopsies	15
Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice	15
The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration	15
Novel insights into meningioma brain invasion with spatial transcriptomic profiling	14
Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic	14
Correction: Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomas	14
LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease	14
Publisher Correction: Exploring the significance of caspase-cleaved tau in tauopathies and as a complementary pathology to phospho-tau in Alzheimer’s disease: implications for biomarker development an	14
The role of plasminogen activator inhibitor-2 in pneumococcal meningitis	14
Beyond the brain: early autonomic dysfunction in Alzheimer’s disease	14
Clinicopathologic, molecular and tumor immune microenvironment features of mismatch repair-deficient glioblastomas in Lynch syndrome: a multicenter study of 29 cases with therapeutic implications	14
Plasma proteome profiling identifies changes associated to AD but not to FTD	14
Presymptomatic pharmacological inhibition of mGluR5 improves survival in a mouse model of prion diseases	14
High-resolution transcriptomics informs glial pathology in human temporal lobe epilepsy	14
Alcohol-induced damage to the fimbria/fornix reduces hippocampal-prefrontal cortex connection during early abstinence	14
Amygdala granular fuzzy astrocytes are independently associated with both LATE neuropathologic change and argyrophilic grains: a study of Japanese series with a low to moderate Braak stage	14
Disruption of mitochondrial homeostasis and permeability transition pore opening in OPA1 iPSC-derived retinal ganglion cells	14
Quantitative multiplex immunohistochemistry with colorimetric staining (QUIVER) may still benefit from MILAN	14
Acquired neuropathology and its associations with key patterns of placental pathology	14
RNF168 dephosphorylation ameliorates cognitive decline in Aβ-based mouse models of Alzheimer’s disease	14
Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion	13
Wolfram syndrome 1b mutation suppresses Mauthner-cell axon regeneration via ER stress signal pathway	13
Hippocampal capillary pericytes in post-stroke and vascular dementias and Alzheimer’s disease and experimental chronic cerebral hypoperfusion	13
Rapid intraoperative boundary diagnosis of somatotroph pituitary neuroendocrine tumors using real-time PCR	13
Glioblastoma CD105+ cells define a SOX2− cancer stem cell-like subpopulation in the pre-invasive niche	13
Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer’s disease mouse model	13
CNS embryonal tumour with concomitant novel BRD4::CTRC1 fusion and BCOR internal tandem duplication – evidence for synergism and non-mutually exclusive alterations in CNS embryonal tumours	13
Traumatic brain injury induces TDP-43 mislocalization and neurodegenerative effects in tissue distal to the primary injury site in a non-transgenic mouse	13
Correction: The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes	13
EZHIP boosts neuronal-like synaptic gene programs and depresses polyamine metabolism	13
Homozygous CDKN2A/B deletions in low- and high-grade glioma: a meta-analysis of individual patient data and predictive values of p16 immunohistochemistry testing	13
Pituitary blastoma in a dog: comparative clinical, imaging, and pathologic features of a newly recognized and rare human entity	13
Cerebrovascular p16INK4A expression induces cerebral small vessel disease-related phenotypes	13
Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort	13
Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling	13
Combination therapy of adagrasib and abemaciclib in non-small cell lung cancer brain metastasis models genomically characterized by KRAS-G12C and homozygous loss of CDKN2A	13
On the origin and development of glioblastoma: multifaceted role of perivascular mesenchymal stromal cells	13
PRC2 disruption in cerebellar progenitors produces cerebellar hypoplasia and aberrant myoid differentiation without blocking medulloblastoma growth	13
Correction to: Dynamic profiling of medulloblastoma surfaceome	13
A mouse model of stereotactic radiosurgery-induced neuroinflammation and blood-brain barrier compromise	13
Lack of junctional adhesion molecule (JAM)-B traps CD8 T cells in CNS border zones and ameliorates autoimmune neuroinflammation	13
Expression of LTR and LINE1 transposable elements defines atypical teratoid/rhabdoid tumor subtypes	12
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators	12
Adequate post-ischemic reperfusion of the mouse brain requires endothelial NFAT5	12
Pharmacological inhibition of SPAK-NKCC1 complex attenuates astrogliosis and restores cerebral blood flow in a mouse model of VCID	12
Genomic and immune profiling of breast cancer brain metastases	12
Partial normalization of hippocampal oscillatory activity during sleep in TgF344-AD rats coincides with increased cholinergic synapses at early-plaque stage of Alzheimer’s disease	12
Brain macrophages and pial fibroblasts promote inflammation in a hypomyelination model	12
AQP4-specific T cells determine lesion localization in the CNS in a model of NMOSD	12
Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19	12
Organoids and chimeras: the hopeful fusion transforming traumatic brain injury research	12
Abnormal accumulation of extracellular vesicles in hippocampal dystrophic axons and regulation by the primary cilia in Alzheimer’s disease	12
Dual targeting of iNOS and Src tyrosine kinase as a superior therapeutic strategy against soman-induced long-term neurotoxicity: multimodal biomarker, imaging, and neurobehavioral outcome analyses	12